By Professor Beng Hock Chong

Journal articles

Heng L; Caguioa P; Chin NS; Chiou TJ; Lee JW; Miyakawa Y; Tambunan KL; Chong BH, 2011, 'Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region', International Journal of Hematology, 94, pp. 142 - 149, http://dx.doi.org/10.1007/s12185-011-0894-8

Hicks C; Isaacs A; Wong RY; Chong BH, 2011, 'CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients', Annals of Hematology, 90, pp. 547 - 555, http://dx.doi.org/10.1007/s00277-010-1097-8

Buller HR; Destors J; Gallus A; Prins MH; Raskob ; Charbonnier B; Decousus H; Leizorovicz A; Laporte G; Brandjes DP; Middeldorp S; Pillion G; Ceresetto J; Hendler H; Xavier D; Santini F; Del carmen gallo M; Coughlin P; Chong BH; al E, 2011, 'Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis', Journal of Thrombosis and Haemostasis, 9, pp. 92 - 99, http://dx.doi.org/10.1111/j.1538-7836.2010.04100.x

Decousus H; Tapson V; Bergmann J; Chong BH; Froehlich J; Kakkar A; Merli G; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos A; Turpie AG; Zotz R; FitzGerald G; Anderson F, 2011, 'Factors at admission associated with bleeding risk in medical patients: Findings from the improve investigators', Chest, 139, pp. 69 - 79, http://dx.doi.org/10.1378/chest.09-3081

Liang S; Khachigian LM; Ahmadi Z; Yang ; Liu S; Chong BH, 2011, 'In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1(+) /CD31(+) side-population cells).', Journal of Thrombosis and Haemostasis, 9, pp. 1628 - 1637, http://dx.doi.org/10.1111/j.1538-7836.2011.04375.x

Chen J; Liu M; Parish CR; Chong BH; Khachigian LM, 2011, 'Nuclear import of early growth response-1 involves importin-7 and the novel nuclear localization signal serine-proline-serine', International Journal of Biochemistry and Cell Biology, 43, pp. 905 - 912, http://dx.doi.org/10.1016/j.biocel.2011.03.004

Choi P; Hock Chong B, 2011, 'Outcomes in primary immune thrombocytopenia (ITP): a retrospective audit on a single tertiary referral centre', Pathology, 43, pp. S56 - S56, http://dx.doi.org/10.1016/s0031-3025(16)33193-2

Choi P; Hock Chong B, 2011, 'Outcomes in primary immune thrombocytopenia (ITP): a retrospective audit on a single tertiary referral centre', Pathology, 43, pp. S61 - S62, http://dx.doi.org/10.1016/s0031-3025(16)33212-3

Spyropoulos A; Anderson F; FitzGerald G; Decousus H; Pini M; Chong BH; et A, 2011, 'Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE.', Chest, 140, pp. 706 - 714, http://dx.doi.org/10.1378/chest.10-1944

Young Ill Choi P; Gemmell R; Hock Chong B, 2011, 'The frequency of renal impairment in patients suspected of heparin induced thrombocytopenia syndrome (HIT)', Pathology, 43, pp. S61 - S61, http://dx.doi.org/10.1016/s0031-3025(16)33210-x

Chong BH; Gan E; Bird R; Pidcock M; Lloyd J; Tay L; Baker R; Stone C; Maher D, 2010, 'An open-label, multicenter study evaluating the efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with primary immune thrombocytopenia (ITP)', Asia-Pacific Journal of Oncology and Hematology, 2

Boccia R; Kuter DJ; Rummel MJ; Macik BG; Pabinger I; Selleslag D; Rodeghiero F; Chong B; Wang X; Lizambri R, 2010, 'The Effects of Romiplostim or Standard of Care (SOC) on Splenectomy and Treatment Failure of Patients Who Had Immune Thrombocytopenia (ITP) for Less Than or Equal to One Year.', Blood, 116, pp. 3702 - 3702, http://dx.doi.org/10.1182/blood.v116.21.3702.3702

Perdomo JS; Fock E; Kaur G; Yan F; Khachigian LM; Jans D; Chong BH, 2010, 'A monopartite sequence is essential for p45 NF-E2 nuclear translocation, transciptional activity and platelet production', Journal of Thrombosis and Haemostasis, 8, pp. 2542 - 2553, http://dx.doi.org/10.1111/j.1538-7836.2010.04058.x

Lassen ; Gallus A; Raskob ; Pineo ; Chen ; Ramirez ; Chong BH, 2010, 'Apixaban versus enoxaparin for thromboprophylaxis after hip replacement', New England Journal of Medicine, 363, pp. 2487 - 2498

Liang S; Tan TY; Gaudry L; Chong BH, 2010, 'Differentiation and migration of Sca1+/CD31− cardiac side population cells in a murine myocardial ischemic model', International Journal of Cardiology, 138, pp. 40 - 49, http://dx.doi.org/10.1016/j.ijcard.2008.08.032

Liang SX; Pinkevych M; Khachigian LM; Parish CR; Davenport MP; Chong BH, 2010, 'Drug-induced thrombocytopenia (DITP): development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG', Blood, 116, pp. 1958 - 1960

Chong BH, 2010, 'Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial', Annals of Internal Medicine, 153, pp. 8 - 18

Chong BH, 2010, 'Heparin-induced thrombocytopenia associated with fondaparinux', Clin Adv Hematol Oncol, 8, pp. 63 - 65

Chong BH, 2010, 'International consensus report on the investigation and management of primary immune thrombocytopenia.', Blood, 115, pp. 168 - 186

Chong BH, 2010, 'IVIg immune inhibitory activity: APC is key.', Blood, 115, pp. 1663 - 1664

Chong BH; Bird R; Pidcock M; Lloyd J; Taylor L; Lloyd J; Baker RW; Stone C; Maher D, 2010, 'open-label, multicenter study evaluating the efficacy and safety of a new 10% liquid intravenous immunoglobulin (Intragam 10 NF) in patients with primary immune thrombocytopenia (ITP)', Asia-Pacific Journal of Oncology & Hematology, 2, pp. 7 - 12

Chong BH, 2010, 'Oral rivaroxaban for symptomatic venous thromboembolism', New England Journal of Medicine, 363, pp. 2499 - 2510

Wang B; Chen J; Santiago FS; Janes ME; Kavurma MM; Chong BH; Pimanda JE; Khachigian LM, 2010, 'Phosphorylation and acetylation of histone H3 and autoregulation by early growth response 1 mediate interleukin 1beta induction of early growth response 1 transcription.', Arteriosclerosis, Thrombosis and Vascular Biology, 30, pp. 536 - 545, http://dx.doi.org/10.1161/ATVBAHA.109.193821

Ye ; Chan G; Qiao ; Meng ; Luo ; Khachigian LM; Ma ; Deng R; Chen ; Chong BH; Yang , 2010, 'Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway', Haematologica, 95, pp. 1745 - 1753

Liu C; Li J; Meng ; Liang SX; Deng R; Li C; Pong NH; Lau CP; Cheng SW; Ye ; Chen JL; Yang S; Yan H; Chen S; Chong BH; Yang M, 2010, 'Polysaccharides from the root of Angelica sinensis promotes hematopoiesis and thrombopoiesis through the PI3K/AKT pathway', BMC Complementary and Alternative Medicine, 10:79, pp. 1 - 12, http://dx.doi.org/10.1186/1472-6882-10-79

Kuter D; Rummel M; Boccia R; Macik B; Pabinger I; Selleslag D; Rodeghiero F; Chong BH; Wang X; Berger D, 2010, 'Romiplostim or standard of care in patients with immune thrombocytopenia', New England Journal of Medicine, 363, pp. 1889 - 1999

Kidson-Gerber GL; Weaver J; Gemmell R; Prasan A; Chong BH, 2010, 'Serum Thromboxane B2 Compared to Five Other Platelet Function Tests for the Evaluation of Aspirin Effect in Stable Cardiovascular Disease', Heart Lung and Circulation, 19, pp. 234 - 242, http://dx.doi.org/10.1016/j.hlc.2009.11.002

Kuter DJ; Rummel MJ; Boccia RV; Macik BG; Pabinger I; Selleslag DLD; Rodeghiero F; Chong BH; Müller-Beiβenhirtz H; Gehl L; Wang X; Berger D, 2009, 'Comparison of Splenectomy and Treatment Failure Incidence in Nonsplenectomized Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim or Medical Standard of Care: 1-Year Treatment and 6-Month Safety Follow-up.', Blood, 114, pp. 679 - 679, http://dx.doi.org/10.1182/blood.v114.22.679.679

Shantsila E; Lip G; Chong BH, 2009, 'Heparin-Induced Thrombocytopenia A Contemporary Clinical Approach to Diagnosis and Management', Chest, 135, pp. 1651 - 1664

Chong BH; Isaacs A, 2009, 'Heparin-induced thrombocytopenia: what clinicians need to know.', Journal of Thrombosis and Haemostasis, 101, pp. 279 - 283, http://www.schattauer.de/en/magazine/subject-areas/journals-a-z/thrombosis-and-haemostasis/contents/archive/issue/716/manuscript/10924.html

Shantsila E; Lip G; Chong BH, 2009, 'Heparin-induced thrombocytopenia. A contemporary clinical', Chest, 135, pp. 1651 - 1664, http://chestjournal.chestpubs.org/content/135/6/1651.long

Chong BH, 2009, 'Primary immune thrombocytopenia: Understanding pathogenesis is the key to better treatments', Journal of Thrombosis and Haemostasis, 7, pp. 319 - 321, http://dx.doi.org/10.1111/j.1538-7836.2008.03258.x

Rodeghiero F; Stasi R; Gernsheimer T; Michel M; Provan D; Arnold D; Bussel J; Cines D; Chong BH; Cooper N; Godeau B; Lechner K; Mazzucconi M; Mcmillan R; Sanz M; Imbach P; Blanchette V; Kuhne T; Ruggeri M; George J, 2009, 'Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group', Blood, 113, pp. 2386 - 2393, http://bloodjournal.hematologylibrary.org/cgi/content/full/113/11/2386

Chapman NH; Brighton TA; Harris MF; Caplan GA; Braithwaite J; Chong BH, 2009, 'Zylna zatorowoϾ zakrzepowa (Venous thromboembolism)', Lekarz Rodzinny, 142, pp. 596 - 601, http://rodzinni.org/Article/Show,20621.html

Kidson-Gerber GL; Gemmell R; Weaver J; Chong BH, 2008, 'A prospective study of aspirin and clopidogrel resistance in patients with cardiovascular disease: compression of serum thromboxane B2 measurements with the results of whole blood aggregometry, PFA 100, cone & plate analyser and verifyNow system', INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 30, pp. 13 - 14

Fock E; Yan F; Pan SW; Chong BH, 2008, 'NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo', Experimental Hematology, 36, pp. 78 - 92, http://dx.doi.org/10.1016/j.exphem.2007.08.015

Yang M; Ng MH; Li C; Chan PK; Liu C; Ye J; Chong BH, 2008, 'Thrombopoietin levels increased in patients with severe acute respiratory syndrome', Thrombosis Research, 122, pp. 473 - 477

Chong BH; Braithwaite J; Harris MF; Fletcher J, 2008, 'Venous thromboembolism - a major health and financial burden: how can we do better to prevent this disease?', Medical Journal of Australia, 189, pp. 134 - 135

Philips AS; Kwok JC; Chong BH, 2007, 'Analysis of the signals and mechanisms mediating nuclear trafficking of GATA-4: Loss of DNA binding is associated with localization in intranuclear speckles', The Journal of Biological Chemistry, 282, pp. 24915 - 24927, http://dx.doi.org/10.1074/jbc.M701789200

Gao R; Chen X; Lin X; Qian X; Xu WJ; Chong BH, 2007, 'Effects of notoginosides on proliferation and upregulation of GR nuclear transcription factor in hematopoietic cells', ACTA Pharmacologica Sinica, 28, pp. 703 - 711

Kwok JC; Perdomo JS; Chong BH, 2007, 'Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes', Journal of Cellular Biochemistry, 101, pp. 1456 - 1474

Chong BH; Lee SH, 2007, 'Management of thromboembolism in hematologic malignancies', Seminars in Thrombosis and Hemostasis, 33, pp. 435 - 447

Fock E; Yan F; Chong BH, 2007, 'NF-E2 mediated enhancement of megakaryocytic differentation and platelet production in vitro and in vivo', Experimental Hematology, 35, pp. 35 - 36

Tapson V; Decousus H; Pini M; Chong BH; Et A, 2007, 'Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism', Chest, 132, pp. 936 - 945

Qi J; Wang JQ; Mandadi S; Tanaka K; Roufogalis BD; Madigan MC; Lai K; Yan F; Chong BH; Stevens RL; Krilis S, 2006, 'Human and mouse mast cells use the Tetraspanin CD9 as an alternate Interleukin 16 receptor', Blood, 107, pp. 135 - 142

Fock E; Yan F; Chong BH, 2006, 'Proplatelet production from haematopoeitic stem cells enhanced by NF-E2 overexpression', Cytotherapy, 8

Aster R; Curtis B; Bougie D; Dunkley S; Greinacher A; Warkentin T; Chong BH, 2006, 'Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors', Journal of Thrombosis and Haemostasis, 4, pp. 678 - 679

Decousus H; Zotz RB; Tapson VF; Chong BH; Froehlich JB; Pavanello R; Spyropoulos AC; Monreal M; FitzGerald G; Anderson FA, 2005, 'Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).', Blood, 106, pp. 264 - 264, http://dx.doi.org/10.1182/blood.v106.11.264.264

Monreal M; Zotz RB; Decousus H; Chong BH; Merli G; Pavanello R; Pini M; Turpie AGG; Huang W; Anderson FA, 2005, 'Influence of Perceived Risk Factors for Bleeding on Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients: Findings from IMPROVE.', Blood, 106, pp. 917 - 917, http://dx.doi.org/10.1182/blood.v106.11.917.917

Chan EM; Corner EM; Brown FC; Richkind KE; Holmes ML; Chong BH; Shiffman R; Zhang D; Slovak ML; Willman CL; Noguchi CT; Li Y; Heiber DJ; Kwan L; Chan R; Vance GH; Ramsay H; Hromas R, 2005, 'AML1-FOG2 fusion protein myelodyspasia', Blood, 105, pp. 4523 - 4526

Back to profile page